Listen as two urologists discuss everything you need to know about Active Surveillance.
To conduct a PSA test, a physician will take a blood sample and send it to a laboratory for analysis. A PSA test result is an important factor when determining prostate cancer diagnosis, plan and treatment. However, an elevated PSA does not always mean a man has prostate cancer. Additionally, a low PSA does not mean that cancer is not present.
PSA tests measure the level of prostate-specific antigen in your blood. This protein, produced by the prostate gland, can be elevated due to prostate cancer, benign enlargement, or inflammation. The main goal of PSA testing is early detection of potential prostate cancer before symptoms appear. Early detection allows for timely intervention, which can significantly impact treatment outcomes.
Deciding whether to have a PSA test is a personal choice best made with your healthcare provider. Several factors influence this decision, including your age, family history of prostate cancer, ethnicity, and overall health. Men with higher risk factors, such as a strong family history or African American heritage, may benefit from earlier screening. It’s crucial to discuss with your doctor the potential benefits of early detection versus the risks of overdiagnosis and unnecessary treatment. Your healthcare provider can help you make an informed decision based on your individual circumstances.
Doctors often recommend PSA testing in men 55 and older. However, your doctor may recommend testing your levels at an earlier age if you have known risk factors for prostate cancer, including family history of the disease or the known presence of a germline mutation.
In general, doctors often consider PSA levels of 3.9 ng/mL and lower to be normal depending on your age. It is also important for your doctor to track any increases in your PSA levels as these increases may suggest the presence of cancer even if your PSA is in the normal range.
According to American Cancer Society, men with a PSA level between 4.0 and 10.0 ng/mL have a 25% chance of having prostate cancer. For men with a PSA level greater than 10.0 ng/mL, the chance of prostate cancer is over 50%.1
Consult with your physician regarding PSA results and PSA ranges.
While PSA levels under 4.0 ng/mL are typically considered normal for most men, it’s important to note that “normal” can vary with age. Older men may naturally have higher levels. Your doctor will interpret your results in the context of your overall health and risk factors.
As mentioned above, a high PSA doesn’t always mean a man has prostate cancer. PSA levels can be elevated because of several benign conditions.
Your healthcare provider will consider various factors when interpreting your PSA test results.
If your PSA test shows higher-than-expected levels, your doctor will likely recommend additional steps to determine the cause. These may include:
Your healthcare provider will guide you through these options, taking into account the degree of PSA elevation, your individual health profile, and your family history. Prostate cancer genetic testing can provide valuable insights into your cancer risk and may influence further diagnostic and treatment decisions. Remember, elevated PSA levels don’t automatically mean you have cancer, but they do warrant further investigation.
PSA testing offers both advantages and potential drawbacks. It’s important to discuss these with your healthcare provider to make an informed decision about screening.
Remember, PSA testing is just one tool in prostate health management. Your doctor can help you weigh these factors based on your individual health profile and risk factors.
A Digital Rectal Exam (DRE) is another important screening tool for prostate cancer. During this in-office procedure, your doctor examines the prostate gland by inserting a lubricated, gloved finger into the rectum. This allows them to feel for any abnormalities or enlargement of the prostate.
What to expect:
If your PSA levels or DRE results raise concerns, your doctor may recommend further testing.
A prostate biopsy is typically performed to confirm the presence of cancer when PSA levels are elevated, or a DRE reveals abnormalities. This procedure involves taking small tissue samples from your prostate for examination.
If cancer is found in your biopsy samples, pathologists use Gleason scoring to grade the cancer’s aggressiveness. This scoring system is crucial for determining appropriate treatment options.
How it works:
Example: A Gleason score of 3+4=7 means the primary pattern is grade 3, and the secondary pattern is grade 4.
It’s important to note that while Gleason scoring is valuable, it has limitations. Scoring can be subjective and may vary between pathologists. Your doctor might recommend additional testing, such as the Prolaris test, for a more comprehensive assessment of your cancer’s aggressiveness.
Remember, these screening methods work together with PSA testing to provide a fuller picture of your prostate health. Always discuss the results and their implications with your healthcare provider.